zoledronic acid has been researched along with Granulocytic Leukemia, Chronic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avci, CB; Baran, Y; Gokbulut, AA; Gunduz, C; Iskender, G; Kiper, HD; Kosova, B; Sahin, F; Saydam, G; Selvi, N; Tezcanli Kaymaz, B; Yandim, MK | 1 |
| Agosto, S; Ahmadi, S; Bruder, JM; Koops, M; Toro-Tobón, D | 1 |
| Caccamo, N; D'Asaro, M; Di Liberto, D; Di Raimondo, F; Dieli, F; Fourniè, JJ; Guggino, G; La Mendola, C; Meraviglia, S; Messina, A; Orlando, V; Salerno, A; Spina, M; Stassi, G; Todaro, M; Vigneri, P | 1 |
| Furukawa, T; Iwabuchi, M; Narita, M; Sato, N; Sone, H; Takahashi, M; Uchiyama, T; Yamahira, A | 1 |
| Enjo, F; Kimura, S; Kobayashi, Y; Kuroda, J; Maekawa, T; Ottmann, OG; Segawa, H; Tokuda, H; Ueda, T; Urasaki, Y; Yoshikawa, T | 1 |
| Kimura, S; Kuroda, J; Maekawa, T; Nogawa, M; Ottmann, OG; Sato, K; Segawa, H; Yuasa, T | 1 |
| Ashihara, E; Fujiyama, Y; Kamitsuji, Y; Kawata, E; Kimura, S; Kuroda, J; Maekawa, T; Ottmann, OG; Sato, K; Segawa, H; Yokota, A; Yuasa, T | 1 |
| Barnes, DJ; Chuah, C; Corbin, A; Deininger, MW; Druker, BJ; Kwok, M; Melo, JV | 1 |
| Andreasson, C; Apperley, JF; Chuah, C; Goldman, JM; Kaeda, J; Marin, D; Pavlu, J | 1 |
1 review(s) available for zoledronic acid and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review.
Topics: Blast Crisis; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Humans; Hypercalcemia; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Zoledronic Acid | 2017 |
1 trial(s) available for zoledronic acid and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remission.
Topics: Adult; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Cytogenetic Analysis; Diphosphonates; Drug Administration Schedule; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; ras Proteins; Remission Induction; Signal Transduction; Zoledronic Acid | 2007 |
7 other study(ies) available for zoledronic acid and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Signal Transduction; STAT Transcription Factors; Zoledronic Acid | 2013 |
V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.
Topics: Adult; Animals; Benzamides; Cells, Cultured; Coculture Techniques; Diphosphonates; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Activation; Mice; Mice, SCID; Piperazines; Pyrimidines; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes, Cytotoxic; Zoledronic Acid | 2010 |
Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study.
Topics: Adult; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Division; Cells, Cultured; Coculture Techniques; Cytotoxicity, Immunologic; Dasatinib; Diphosphonates; Dose-Response Relationship, Drug; Humans; Imidazoles; Interleukin-2; K562 Cells; Killer Cells, Natural; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocytosis; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Receptors, Antigen, T-Cell, gamma-delta; Stimulation, Chemical; T-Lymphocyte Subsets; Thiazoles; Zoledronic Acid | 2013 |
The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Cell Division; Diphosphonates; Drug Synergism; Hematopoietic Stem Cells; HL-60 Cells; Humans; Imatinib Mesylate; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred NOD; Mice, SCID; Monomeric GTP-Binding Proteins; Pamidronate; Piperazines; Protein Prenylation; Pyrimidines; Zoledronic Acid | 2003 |
Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines.
Topics: Antineoplastic Agents; Benzamides; Cell Death; Cell Division; Cell Line, Tumor; Cytarabine; Daunorubicin; Diphosphonates; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydroxyurea; Imatinib Mesylate; Imidazoles; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Piperazines; Pyrimidines; Vincristine; Zoledronic Acid | 2004 |
Zoledronate synergises with imatinib mesylate to inhibit Ph primary leukaemic cell growth.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Diphosphonates; Drug Synergism; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, SCID; Models, Animal; Neoplasm Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Tumor Cells, Cultured; Zoledronic Acid | 2005 |
Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Cell Proliferation; Diphosphonates; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Genes, abl; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Tumor Cells, Cultured; Zoledronic Acid | 2005 |